Published in ISRN Endocrinol on July 09, 2013
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 9.79
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med (2007) 5.89
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem (2003) 5.40
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med (2010) 4.96
Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem (2003) 4.08
Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem (2003) 2.29
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care (2003) 2.05
Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes (2007) 1.98
Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem (2003) 1.70
The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol (2005) 1.24
Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans. Obesity (Silver Spring) (2008) 1.14
Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes (2007) 1.13
Biovariability of plasma adiponectin. Clin Chem Lab Med (2006) 1.07
Sociocultural factors relating to Tongans' and Indigenous Fijians' patterns of eating, physical activity and body size. Asia Pac J Clin Nutr (2008) 1.05
Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest (2008) 1.04
Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant (2006) 1.01
The prevalence of diabetes in the kingdom of Tonga. Diabetes Care (2002) 0.99
Heritability of plasma adiponectin levels and body mass index in twins. J Clin Endocrinol Metab (2007) 0.99
Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study. J Intern Med (2009) 0.96
Obesity, Type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population. Clin Sci (Lond) (2003) 0.91
Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans. Curr Diab Rep (2005) 0.88
Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb (2009) 0.87
The effects of macronutrient intake on total and high-molecular weight adiponectin: results from the OMNI-Heart trial. Obesity (Silver Spring) (2009) 0.83
Diet, health and the nutrition transition: some impacts of economic and socio-economic factors on food consumption patterns in the Kingdom of Tonga. Pac Health Dialog (2002) 0.83
Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in Tongans. BMC Med Genet (2011) 0.83
Differences in body composition between Tongans and Australians: time to rethink the healthy weight ranges? Int J Obes Relat Metab Disord (2001) 0.81
Comparison of plasma adiponectin levels in New Zealand Maori and Caucasian individuals. N Z Med J (2007) 0.80
BMI inaccurately reflects total body and abdominal fat in Tongans. Acta Diabetol (2003) 0.77
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care (2003) 5.44
Insulin levels in insulin resistance: phantom of the metabolic opera? Med J Aust (2006) 5.33
The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care (2002) 4.52
Outcome of overseas commercial kidney transplantation: an Australian perspective. Med J Aust (2005) 3.22
Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des (2008) 2.65
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust (2010) 2.44
Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev (2009) 2.43
Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care (2007) 2.30
Childhood obesity in Australia remains a widespread health concern that warrants population-wide prevention programs. Med J Aust (2009) 2.24
Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. J Clin Endocrinol Metab (2007) 2.20
Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care (2006) 1.68
Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust (2009) 1.67
Diabetes guidelines: easier to preach than to practise? Med J Aust (2006) 1.61
Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation (2004) 1.59
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000. Med J Aust (2008) 1.45
Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. Med J Aust (2012) 1.40
Trade and the nutrition transition: strengthening policy for health in the Pacific. Ecol Food Nutr (2011) 1.35
Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. Diabetes Care (2005) 1.31
Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care (2004) 1.31
Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev (2006) 1.30
Translating research for evidence-based public health: key concepts and future directions. J Epidemiol Community Health (2012) 1.26
Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment. Diabetes Res Clin Pract (2012) 1.26
Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis (2008) 1.26
The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol (2005) 1.24
Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography. Obes Res (2002) 1.24
Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes (2010) 1.21
The answer to diabetes prevention: science, surgery, service delivery, or social policy? Am J Public Health (2006) 1.15
Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care (2004) 1.14
Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes (2007) 1.13
Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content. Metabolism (2003) 1.13
Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator? Diabetes Care (2003) 1.12
Chronic diseases and multi-morbidity--a conceptual modification to the WHO ICCC model for countries in health transition. BMC Public Health (2014) 1.12
The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Med J Aust (2012) 1.10
Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection. Obesity (Silver Spring) (2008) 1.09
Sugar-sweetened beverages, genetic risk, and obesity. N Engl J Med (2013) 1.07
Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord (2008) 1.04
Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun (2006) 1.04
The cost of diabetes in adults in Australia. Diabetes Res Clin Pract (2013) 1.03
Vitamin D insufficiency--a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf) (2008) 1.03
Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun (2008) 1.02
Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care (2008) 1.00
Improving the estimation of mealtime insulin dose in adults with type 1 diabetes: the Normal Insulin Demand for Dose Adjustment (NIDDA) study. Diabetes Care (2011) 1.00
Diabetic ketoacidosis: the usual villain or a scapegoat? A novel cause of severe metabolic acidosis in type 1 diabetes. Diabetes Care (2008) 0.97
Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res (2003) 0.97
HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia (2013) 0.97
The Australian Primary Care Collaboratives Program: improving diabetes care. BMJ Qual Saf (2012) 0.97
Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus--practical implications. Diabetes Res Clin Pract (2011) 0.95
Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab (2004) 0.95
The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract (2008) 0.94
Moderate alcohol consumption, dietary fat composition, and abdominal obesity in women: evidence for gene-environment interaction. J Clin Endocrinol Metab (2003) 0.94
Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans. PLoS One (2012) 0.93
Knowledge deficit of patients with stage 1-4 CKD: a focus group study. Nephrology (Carlton) (2014) 0.93
Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy? Curr Pharm Des (2008) 0.92
Impact of gestational diabetes mellitus screening strategies on perinatal outcomes: a simulation study. Diabetes Res Clin Pract (2013) 0.92
Glycosylation of human adiponectin affects its conformation and stability. J Mol Endocrinol (2007) 0.92
Estimating the cost of complications of diabetes in Australia using administrative health-care data. Value Health (2008) 0.91
More on body fat cutoff points. Mayo Clin Proc (2011) 0.91
Obesity, Type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population. Clin Sci (Lond) (2003) 0.91
Insulin resistance and postprandial triglyceride levels in primary renal disease. Metabolism (2005) 0.91
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil (2011) 0.91
Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust (2009) 0.91
Factors influencing the cost of hospital care for people with diabetes in Australia. J Diabetes Complications (2006) 0.90
Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index). Int J Cardiol (2006) 0.90
The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring) (2013) 0.89
Postprandial cardiac autonomic function in Prader-Willi syndrome. Clin Endocrinol (Oxf) (2013) 0.88
Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability. Obesity (Silver Spring) (2006) 0.88
Target-seeking behavior of plasma glucose with exercise in type 1 diabetes. Diabetes Care (2003) 0.88
The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2014) 0.86
New IDF Guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract (2014) 0.86
Glycemic index and glycemic load of carbohydrates in the diabetes diet. Curr Diab Rep (2011) 0.86
Insulin resistance and obesity. Clin Dermatol (2004) 0.86
A 45-bp insertion/deletion polymorphism of uncoupling protein 2 in relation to obesity in Tongans. Obes Res (2003) 0.85
Plasma insulin concentration is useful to guide glucose supplement in insulin overdose. Intensive Care Med (2008) 0.85
Does skeletal muscle oxidative stress initiate insulin resistance in genetically predisposed individuals? Trends Endocrinol Metab (2009) 0.84
Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. J Clin Endocrinol Metab (2011) 0.84
Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. J Clin Endocrinol Metab (2010) 0.83
In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides (2011) 0.83
The carnivore connection hypothesis: revisited. J Obes (2011) 0.83
Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America. Diabetes Res Clin Pract (2010) 0.82
Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Diabetes Technol Ther (2004) 0.82
Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab (2003) 0.82
Meta-analysis of low-glycemic index diets in the management of diabetes: response to Franz. Diabetes Care (2003) 0.81
"Mind the gap" when managing ketoacidosis in type 1 diabetes. Diabetes Care (2008) 0.81
Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab (2003) 0.81
Higher-than-optimal body mass index and diabetes mortality in the Asia Pacific region. Diabetes Res Clin Pract (2011) 0.80
The value of the metabolic syndrome concept in elderly adults: is it worth less than the sum of its parts? J Am Geriatr Soc (2012) 0.80
Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humans. PLoS One (2013) 0.80
Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: a study of female twins. J Am Coll Cardiol (2003) 0.79
Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia. BMC Public Health (2014) 0.79
Raised circulating fetuin-a after 28-day overfeeding in healthy humans. Diabetes Care (2014) 0.78
Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides (2006) 0.78
Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population. Med J Aust (2009) 0.78
Back to the future--do IGT and IFG have value as clinical entities? Diabetes Res Clin Pract (2008) 0.78